메뉴 건너뛰기




Volumn 1374, Issue 1, 2016, Pages 10-16

Working with the U.S. Food and Drug Administration to obtain approval of products under the Animal Rule

Author keywords

Animal Rule; efficacy; Food and Drug Administration; safety

Indexed keywords

ANTHRAX VACCINE; BOTULINUM ANTISERUM; CIPROFLOXACIN; FILGRASTIM; HYDROXOCOBALAMIN; LEVOFLOXACIN; MOXIFLOXACIN; OBILTOXAXIMAB; PEGFILGRASTIM; PYRIDOSTIGMINE; RAXIBACUMAB;

EID: 84983490026     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13126     Document Type: Article
Times cited : (15)

References (7)
  • 1
    • 84983527279 scopus 로고    scopus 로고
    • Accessed March 25, 2016
    • Electronic Code of Federal Regulations. 2016. 21 CFR § 600 cf. March 23, 2016. Accessed March 25, 2016. http://www.ecfr.gov/cgi-bin/text-idx?SID=df1ad2a6077548a239df7156665d1cfa&mc=true&tpl=/ecfrbrowse/Title21/21cfrv7_02.tpl#0.
    • (2016) 21 CFR § 600 cf. March 23, 2016
  • 2
    • 84983555784 scopus 로고    scopus 로고
    • 21 CFR § 300 cf. March 23, 2016. Accessed March 25, 2016
    • Electronic Code of Federal Regulations. 2016. 21 CFR § 300 cf. March 23, 2016. Accessed March 25, 2016. http://www.ecfr.gov/cgi-bin/text-idx?SID=df1ad2a6077548a239df7156665d1cfa&mc=true&tpl=/ecfrbrowse/Title21/21cfrv5_02.tpl#0.
    • (2016)
  • 3
    • 84963935694 scopus 로고    scopus 로고
    • Guidance for industry. October 2015. Accessed March 25, 2016
    • FDA. 2015. Product development under the Animal Rule. Guidance for industry. October 2015. Accessed March 25, 2016. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM399217.pdf.
    • (2015) Product development under the Animal Rule
  • 4
    • 84983527291 scopus 로고    scopus 로고
    • March 22, 2016. Accessed May 8, 2016
    • FDA. 2016. Animal Rule information. March 22, 2016. Accessed May 8, 2016. http://www.fda.gov/emergencypreparedness/counterterrorism/medicalcountermeasures/mcmregulatoryscience/ucm391604.htm.
    • (2016) Animal Rule information
  • 5
    • 84983527273 scopus 로고    scopus 로고
    • February 3, 2016. Accessed May 8, 2016
    • FDA. 2016. Combination products guidance documents. February 3, 2016. Accessed May 8, 2016. http://www.fda.gov/regulatoryinformation/guidances/ucm122047.htm.
    • (2016) Combination products guidance documents
  • 6
    • 84983493929 scopus 로고    scopus 로고
    • Guidance for industry and review staff
    • March 2007. Accessed June 8, 2016
    • FDA. 2007. Guidance for industry and review staff. Target product profile—a strategic development process tool. Draft guidance. March 2007. Accessed June 8, 2016. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm080593.pdf.
    • (2007) Target product profile—a strategic development process tool. Draft guidance
  • 7
    • 84983527790 scopus 로고    scopus 로고
    • About FDA. December 7, 2014. Accessed March 25, 2016
    • FDA. 2014. Counter-Terrorism and Emergency Coordination Staff (CTECS). About FDA. December 7, 2014. Accessed March 25, 2016. http://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm320759.htm.
    • (2014) Counter-Terrorism and Emergency Coordination Staff (CTECS)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.